|
1
|
World Health Organization fact sheet
Cancer. February. 2017, http://www.who.int/mediacentre/factsheets/fs297/en/.
|
|
2
|
Tanaka T: Colorectal carcinogenesis:
Review of human and experimental animal studies. J Carcinog.
8:52009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Moore HG, Baxter NN and Guillem JG:
Colorectal cancer: Epidemiology, etiology, and molecular basis. The
ASCRS Textbook of Colon and Rectal Surgery. 2nd edition. Beck D:
Springer Science, Business Media; pp. 669–690. 2011, View Article : Google Scholar
|
|
4
|
Colussi D, Brandi G, Bazzoli F and
Ricciardiello L: Molecular pathways involved in colorectal cancer:
Implications for disease behavior and prevention. Int J Mol Sci.
14:16365–16385. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Markowitz SD and Bertagnolli MM: Molecular
origins of cancer: Molecular basis of colorectal cancer. N Engl J
Med. 361:2449–2460. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Harkins L, Volk AL, Samanta M, Mikolaenko
I, Britt WJ, Bland KI and Cobbs CS: Specific localisation of human
cytomegalovirus nucleic acids and proteins in human colorectal
cancer. Lancet. 360:1557–1563. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen HP, Jiang JK, Chen CY, Chou TY, Chen
YC, Chang YT, Lin SF, Chan CH, Yang CY, Lin CH, et al: Human
cytomegalovirus preferentially infects the neoplastic epithelium of
colorectal cancer: A quantitative and histological analysis. J Clin
Virol. 54:240–244. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen HP, Jiang JK, Lai PY, Chen CY, Chou
TY, Chen YC, Chan CH, Lin SF, Yang CY, Chen CY, et al: Tumoral
presence of human cytomegalovirus is associated with shorter
disease-free survival in elderly patients with colorectal cancer
and higher levels of intratumoral interleukin-17. Clin Microbiol
Infect. 20:664–671. 2014. View Article : Google Scholar
|
|
10
|
Dimberg J, Hong TT, Skarstedt M, Löfgren
S, Zar N and Matussek A: Detection of cytomegalovirus DNA in
colorectal tissue from Swedish and Vietnamese patients with
colorectal cancer. Anticancer Res. 33:4947–4950. 2013.PubMed/NCBI
|
|
11
|
Bai B, Wang X, Chen E and Zhu H: Human
cytomegalovirus infection and colorectal cancer risk: A
meta-analysis. Oncotarget. 7:76735–76742. 2016.PubMed/NCBI
|
|
12
|
Crough T and Khanna R: Immunobiology of
human cytomegalovirus: From bench to bedside. Clin Microbiol Rev.
22:76–98. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Murphy E, Yu D, Grimwood J, Schmutz J,
Dickson M, Jarvis MA, Hahn G, Nelson JA, Myers RM and Shenk TE:
Coding potential of laboratory and clinical strains of human
cytomegalovirus. Proc Natl Acad Sci USA. 100:14976–14981. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Harkins LE, Matlaf LA, Soroceanu L, Klemm
K, Britt WJ, Wang W, Bland KI and Cobbs CS: Detection of human
cytomegalovirus in normal and neoplastic breast epithelium.
Herpesviridae. 1:82010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Samanta M, Harkins L, Klemm K, Britt WJ
and Cobbs CS: High prevalence of human cytomegalovirus in prostatic
intraepithelial neoplasia and prostatic carcinoma. J Urol.
170:998–1002. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Melnick M, Sedghizadeh PP, Allen CM and
Jaskoll T: Human cytomegalovirus and mucoepidermoid carcinoma of
salivary glands: Cell-specific localization of active viral and
oncogenic signaling proteins is confirmatory of a causal
relationship. Exp Mol Pathol. 92:118–125. 2012. View Article : Google Scholar
|
|
17
|
Cobbs CS, Harkins L, Samanta M, Gillespie
GY, Bharara S, King PH, Nabors LB, Cobbs CG and Britt WJ: Human
cytomegalovirus infection and expression in human malignant glioma.
Cancer Res. 62:3347–3350. 2002.PubMed/NCBI
|
|
18
|
Rahbar A, Orrego A, Peredo I, Dzabic M,
Wolmer-Solberg N, Strååt K, Stragliotto G and Söderberg-Nauclér C:
Human cytomegalovirus infection levels in glioblastoma multiforme
are of prognostic value for survival. J Clin Virol. 57:36–42. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Stragliotto G, Rahbar A, Solberg NW, Lilja
A, Taher C, Orrego A, Bjurman B, Tammik C, Skarman P, Peredo I, et
al: Effects of valganciclovir as an add-on therapy in patients with
cytomegalovirus-positive glioblastoma: A randomized, double-blind,
hypothesis-generating study. Int J Cancer. 133:1204–1213. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wolmer-Solberg N, Baryawno N, Rahbar A,
Fuchs D, Odeberg J, Taher C, Wilhelmi V, Milosevic J, Mohammad AA,
Martinsson T, et al: Frequent detection of human cytomegalovirus in
neuroblastoma: A novel therapeutic target? Int J Cancer.
133:2351–2361. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Michaelis M, Doerr HW and Cinatl J Jr: The
story of human cytomegalovirus and cancer: Increasing evidence and
open questions. Neoplasia. 11:1–9. 2009. View Article : Google Scholar
|
|
22
|
Söderberg-Nauclér C and Nelson JY: Human
cytomegalovirus latency and reactivation - a delicate balance
between the virus and its host's immune system. Intervirology.
42:314–321. 1999. View Article : Google Scholar
|
|
23
|
Reeves MB, Davies AA, McSharry BP,
Wilkinson GW and Sinclair JH: Complex I binding by a virally
encoded RNA regulates mitochondria-induced cell death. Science.
316:1345–1348. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cobbs CS, Soroceanu L, Denham S, Zhang W,
Britt WJ, Pieper R and Kraus MH: Human cytomegalovirus induces
cellular tyrosine kinase signaling and promotes glioma cell
invasiveness. J Neurooncol. 85:271–280. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cobbs CS, Soroceanu L, Denham S, Zhang W
and Kraus MH: Modulation of oncogenic phenotype in human glioma
cells by cytomegalovirus IE1-mediated mitogenicity. Cancer Res.
68:724–730. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fiallos E, Judkins J, Matlaf L, Prichard
M, Dittmer D, Cobbs C and Soroceanu L: Human cytomegalovirus gene
expression in long-term infected glioma stem cells. PLoS One.
9:e1161782014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Soroceanu L, Matlaf L, Khan S, Akhavan A,
Singer E, Bezrookove V, Decker S, Ghanny S, Hadaczek P, Bengtsson
H, et al: Cytomegalovirus immediate-early proteins promote stemness
properties in glioblastoma. Cancer Res. 75:3065–3076. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fornara O, Bartek J Jr, Rahbar A, Odeberg
J, Khan Z, Peredo I, Hamerlik P, Bartek J, Stragliotto G, Landázuri
N, et al: Cytomegalovirus infection induces a stem cell phenotype
in human primary glioblastoma cells: Prognostic significance and
biological impact. Cell Death Differ. 23:261–269. 2016. View Article : Google Scholar :
|
|
29
|
Abdul Khalek FJ, Gallicano GI and Mishra
L: Colon cancer stem cells. Gastrointest Cancer Res. (Suppl 1):
S16–S23. 2010.
|
|
30
|
Papailiou J, Bramis KJ, Gazouli M and
Theodoropoulos G: Stem cells in colon cancer. A new era in cancer
theory begins. Int J Colorectal Dis. 26:1–11. 2011. View Article : Google Scholar
|
|
31
|
Du L, Wang H, He L, Zhang J, Ni B, Wang X,
Jin H, Cahuzac N, Mehrpour M, Lu Y, et al: CD44 is of functional
importance for colorectal cancer stem cells. Clin Cancer Res.
14:6751–6760. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gorham H, Sugino T, Woodman AC and Tarin
D: Cellular distribution of CD44 gene transcripts in colorectal
carcinomas and in normal colonic mucosa. J Clin Pathol. 49:482–488.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wu TC, Lee WA, Pizzorno MC, Au WC, Chan
YJ, Hruban RH, Hutchins GM and Hayward GS: Localization of the
human cytomegalovirus 2.7-kb major early beta-gene transcripts by
RNA in situ hybridization in permissive and nonpermissive
infections. Am J Pathol. 141:1247–1254. 1992.PubMed/NCBI
|
|
34
|
Cano A, Pérez-Moreno MA, Rodrigo I,
Locascio A, Blanco MJ, del Barrio MG, Portillo F and Nieto MA: The
transcription factor snail controls epithelial-mesenchymal
transitions by repressing E-cadherin expression. Nat Cell Biol.
2:76–83. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yang J, Mani SA, Donaher JL, Ramaswamy S,
Itzykson RA, Come C, Savagner P, Gitelman I, Richardson A and
Weinberg RA: Twist, a master regulator of morphogenesis, plays an
essential role in tumor metastasis. Cell. 117:927–939. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Mocarski E and Shenk T: Cytomegaloviruses.
Fields Virology. 5th edition. Knipe D and Howley P: Lippincott
Williams and Wilkins; Philadelphia, PA: pp. 2701–2772. 2007
|
|
37
|
Fortunato EA and Spector DH: Regulation of
human cytomegalovirus gene expression. Adv Virus Res. 54:61–128.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Landolfo S, Gariglio M, Gribaudo G and
Lembo D: The human cytomegalovirus. Pharmacol Ther. 98:269–297.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chen HP, Jiang JK, Chan CH, Teo WH, Yang
CY, Chen YC, Chou TY, Lin CH and Chan YJ: Genetic polymorphisms of
the human cytomegalovirus UL144 gene in colorectal cancer and its
association with clinical outcome. J Gen Virol. 96:3613–3623. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Jiang BH and Liu LZ: PI3K/PTEN signaling
in angiogenesis and tumorigenesis. Adv Cancer Res. 102:19–65. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Suman S, Kurisetty V, Das TP, Vadodkar A,
Ramos G, Lakshmanaswamy R and Damodaran C: Activation of AKT
signaling promotes epithelial-mesenchymal transition and tumor
growth in colorectal cancer cells. Mol Carcinog. 53(Suppl 1):
E151–E160. 2014. View Article : Google Scholar
|
|
42
|
Porta C, Paglino C and Mosca A: Targeting
PI3K/Akt/mTOR signaling in cancer. Front Oncol. 4:642014.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Mayer IA and Arteaga CL: The PI3K/AKT
pathway as a target for cancer treatment. Annu Rev Med. 67:11–28.
2016. View Article : Google Scholar
|
|
44
|
Cobbs C, Khan S, Matlaf L, McAllister S,
Zider A, Yount G, Rahlin K, Harkins L, Bezrookove V, Singer E, et
al: HCMV glycoprotein B is expressed in primary glioblastomas and
enhances growth and invasiveness via PDGFR-alpha activation.
Oncotarget. 5:1091–1100. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Yurochko AD, Kowalik TF, Huong SM and
Huang ES: Human cytomegalovirus upregulates NF-kappa B activity by
transactivating the NF-kappa B p105/p50 and p65 promoters. J Virol.
69:5391–5400. 1995.PubMed/NCBI
|
|
46
|
Castillo JP, Yurochko AD and Kowalik TF:
Role of human cytomegalovirus immediate-early proteins in cell
growth control. J Virol. 74:8028–8037. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Moorman NJ, Cristea IM, Terhune SS, Rout
MP, Chait BT and Shenk T: Human cytomegalovirus protein UL38
inhibits host cell stress responses by antagonizing the tuberous
sclerosis protein complex. Cell Host Microbe. 3:253–262. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Streblow DN, Soderberg-Naucler C, Vieira
J, Smith P, Wakabayashi E, Ruchti F, Mattison K, Altschuler Y and
Nelson JA: The human cytomegalovirus chemokine receptor US28
mediates vascular smooth muscle cell migration. Cell. 99:511–520.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Maussang D, Verzijl D, van Walsum M, Leurs
R, Holl J, Pleskoff O, Michel D, van Dongen GA and Smit MJ: Human
cytomegalovirus-encoded chemokine receptor US28 promotes
tumorigenesis. Proc Natl Acad Sci USA. 103:13068–13073. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Maussang D, Langemeijer E, Fitzsimons CP,
Stigter-van Walsum M, Dijkman R, Borg MK, Slinger E, Schreiber A,
Michel D, Tensen CP, et al: The human cytomegalovirus-encoded
chemokine receptor US28 promotes angiogenesis and tumor formation
via cyclooxygenase-2. Cancer Res. 69:2861–2869. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Slinger E, Maussang D, Schreiber A,
Siderius M, Rahbar A, Fraile-Ramos A, Lira SA, Söderberg-Nauclér C
and Smit MJ: HCMV-encoded chemokine receptor US28 mediates
proliferative signaling through the IL-6-STAT3 axis. Sci Signal.
3:ra582010. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Bongers G, Maussang D, Muniz LR, Noriega
VM, Fraile-Ramos A, Barker N, Marchesi F, Thirunarayanan N, Vischer
HF, Qin L, et al: The cytomegalovirus-encoded chemokine receptor
US28 promotes intestinal neoplasia in transgenic mice. J Clin
Invest. 120:3969–3978. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Cai ZZ, Xu JG, Zhou YH, Zheng JH, Lin KZ,
Zheng SZ, Ye MS, He Y, Liu CB and Xue ZX: Human
cytomegalovirus-encoded US28 may act as a tumor promoter in
colorectal cancer. World J Gastroenterol. 22:2789–2798. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Ding Q, Stewart J Jr, Olman MA, Klobe MR
and Gladson CL: The pattern of enhancement of Src kinase activity
on platelet-derived growth factor stimulation of glioblastoma cells
is affected by the integrin engaged. J Biol Chem. 278:39882–39891.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Zhang J, Tian X-J and Xing J: Signal
transduction pathways of EMT induced by TGF-β, SHH, and WNT and
their crosstalks. J Clin Med. 5:412016. View Article : Google Scholar
|
|
56
|
Derynck R, Muthusamy BP and Saeteurn KY:
Signaling pathway cooperation in TGF-β-induced
epithelial-mesenchymal transition. Curr Opin Cell Biol. 31:56–66.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Takebe N, Harris PJ, Warren RQ and Ivy SP:
Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog
pathways. Nat Rev Clin Oncol. 8:97–106. 2011. View Article : Google Scholar
|
|
58
|
Takebe N, Miele L, Harris PJ, Jeong W,
Bando H, Kahn M, Yang SX and Ivy SP: Targeting Notch, Hedgehog, and
Wnt pathways in cancer stem cells: Clinical update. Nat Rev Clin
Oncol. 12:445–464. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Gonzalez DM and Medici D: Signaling
mechanisms of the epithelial-mesenchymal transition. Sci Signal.
7:re82014. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Jin D, Fang Y, Li Z, Chen Z and Xiang J:
Epithelial-mesenchymal transition-associated microRNAs in
colorectal cancer and drug-targeted therapies (Review). Oncol Rep.
33:515–525. 2015. View Article : Google Scholar
|
|
61
|
Bienz M and Clevers H: Linking colorectal
cancer to Wnt signaling. Cell. 103:311–320. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Polakis P: Wnt signaling and cancer. Genes
Dev. 14:1837–1851. 2000.PubMed/NCBI
|
|
63
|
Novellas de Munt L, Antas P and Li VS:
Targeting Wnt signaling in colorectal cancer. A review in the
theme: Cell signaling: proteins, pathways and mechanisms. Am J
Physiol Cell Physiol. 309:C511–C521. 2015. View Article : Google Scholar
|
|
64
|
Basu S, Haase G and X Ben-Ze'ev A: Wnt
signaling in cancer stem cells and colon cancer metastasis.
F1000Res 5: F1000 Faculty Rev. 699:2016.
|
|
65
|
Brabletz T, Jung A, Reu S, Porzner M,
Hlubek F, Kunz-Schughart LA, Knuechel R and Kirchner T: Variable
beta-catenin expression in colorectal cancers indicates tumor
progression driven by the tumor environment. Proc Natl Acad Sci
USA. 98:10356–10361. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Howard S, Deroo T, Fujita Y and Itasaki N:
A positive role of cadherin in Wnt/β-catenin signalling during
epithelial-mesenchymal transition. PLoS One. 6:e238992011.
View Article : Google Scholar
|
|
67
|
Ueno K, Hazama S, Mitomori S, Nishioka M,
Suehiro Y, Hirata H, Oka M, Imai K, Dahiya R and Hinoda Y:
Down-regulation of frizzled-7 expression decreases survival,
invasion and metastatic capabilities of colon cancer cells. Br J
Cancer. 101:1374–1381. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Nishioka M, Ueno K, Hazama S, Okada T,
Sakai K, Suehiro Y, Okayama N, Hirata H, Oka M, Imai K, et al:
Possible involvement of Wnt11 in colorectal cancer progression. Mol
Carcinog. 52:207–217. 2013. View Article : Google Scholar
|
